HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

AMPAkines have novel analgesic properties in rat models of persistent neuropathic and inflammatory pain.

AbstractBACKGROUND:
Novel analgesics that do not suppress the respiratory drive are urgently needed. Glutamate signaling through α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors plays important roles in central pain circuits. AMPAkines augment AMPA receptor function and have been shown to stimulate the respiratory drive to oppose opioid-induced hypoventilation. However, their role in chronic pain states remains unknown.
METHODS:
The authors studied AMPAkines (CX546 and CX516) in rat spared nerve injury (SNI) model of neuropathic pain and Complete Freund's Adjuvant (CFA) model of inflammatory pain. They measured the effect of AMPAkines on mechanical and cold allodynia. They also evaluated their effect on depressive symptoms of pain using the forced swim test, as time of immobility on this test has been used as a measure for behavioral despair, a feature of depression.
RESULTS:
The authors found that CX546, compared with dimethyl sulfoxide (DMSO) control, reduced both mechanical and sensory allodynia in SNI (DMSO group, n = 9; CX546 group, n = 11) and CFA models (both DMSO and CX546 groups, n = 9). They found that CX546, compared with control, also reduced depressive symptoms of pain by decreasing immobility on the forced swim test in both SNI (both DMSO and CX546 groups, n = 8) and CFA models (both DMSO and CX546 groups, n = 10). Finally, they found that CX516, compared with control, also reduced mechanical and cold allodynia in the SNI model (both DMSO and CX516 groups, n = 10).
CONCLUSIONS:
AMPAkines alleviate pain hypersensitivity as well as depression-like behavior associated with long-lasting nerve injury and inflammatory insult.
AuthorsAlexander M Le, Michelle Lee, Chen Su, Anthony Zou, Jing Wang
JournalAnesthesiology (Anesthesiology) Vol. 121 Issue 5 Pg. 1080-90 (Nov 2014) ISSN: 1528-1175 [Electronic] United States
PMID25338127 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • 1-(1,4-benzodioxan-6-ylcarbonyl)piperidine
  • 1-(quinoxalin-6-ylcarbonyl)piperidine
  • Analgesics
  • Anti-Inflammatory Agents, Non-Steroidal
  • Antidepressive Agents
  • Dioxoles
  • Piperidines
  • Receptors, AMPA
Topics
  • Analgesics (therapeutic use)
  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal (therapeutic use)
  • Antidepressive Agents (pharmacology)
  • Behavior, Animal (drug effects)
  • Dioxoles (therapeutic use)
  • Inflammation (chemically induced, drug therapy)
  • Male
  • Motor Activity (drug effects)
  • Neuralgia (drug therapy)
  • Pain Measurement (drug effects)
  • Piperidines (therapeutic use)
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, AMPA (drug effects)
  • Swimming (psychology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: